Protocol for recombinant RBD-based SARS vaccines: Protein preparation, animal vaccination and neutralization detection

Journal of Visualized Experiments

Volumn , Issue 51, 2011, Pages

  Du, Lanying ^a   Zhang, Xiujuan ^a   Liu, Jixiang ^a   Jiang, Shibo ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

Immunization; Immunology; Issue 51; Neutralization detection; Receptor binding domain; Sars; Subunit vaccines

Indexed keywords

EID: 80355127986     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2444     Document Type: Article

References (16)

1. Pitcovski, J., Gutter B., Gallili, G., Goldway, M., Perelman, B., Gross, G., Krispel, S., Barbakov, M. & Michael, A. Development and large-scale use of recombinant VP2 vaccine for the prevention of infectious bursal disease of chickens. Vaccine 21, 4736-4743 (2003).
2. Tait, A., & Hall, F.R. Theileria annulata: control measures, diagnosis and the potential use of subunit vaccines. Rev. Sci. Tech. 9, 387-403 (1990).
3. Qi, Z., Zhou, L., Zhang, Q., Ren, L., Dai, R., Wu, B., Wang, T., Zhu, Z., Yang, Y., Cui, B., Wang, Z., Wang, H., Qiu, Y., Guo, Z., Yang, R. & Wang, X. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270. Vaccine 28, 1655-1660 (2010).
4. Rosser, M.P., Xia, W., Hartsell, S., McCaman, M., Zhu, Y., Wang, S., Harvey, S., Bringmann, P. & Cobb, R.R. Transient transfection of CHO-K1-S using serum-free medium in suspension: a rapid mammalian protein expression system. Protein Expr. Purif. 40, 237-243 (2005).
5. Du, L., Zhao, G., Li, L., He, Y., Zhou, Y., Zheng, B.J. & Jiang, S. Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells. Biochem. Biophys. Res. Commun. 384, 486-490 (2009).
6. Du, L., Zhao, G., Chan, C.C., Sun, S., Chen, M., Liu, Z., Guo, H., He, Y., Zhou, Y., Zheng, B.J. & Jiang, S. Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. Virology 393, 144-150 (2009).
7. Babcock, G.J., Esshaki, D.J., Thomas, W.D., Jr. & Ambrosino, D.M. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J. Virol. 78, 4552-4560 (2004).
8. Li, W., Moore, M.J., Vasilieva, N., Sui, J., Wong, S.K., Berne, M.A., Somasundaran, M., Sullivan, J.L., Luzuriaga, K., Greenough, T.C., Choe, H. & Farzan, M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450-454 (2003).
9. He, Y., Zhou, Y., Liu, S., Kou, Z., Li, W., Farzan, M. & Jiang, S. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem. Biophys. Res. Commun. 324, 773-781 (2004).
10. Batard, P., Jordan, M. & Wurm, F. Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection. Gene 270, 61-68 (2001).
11. Pramfalk, C., Lanner, J., Andersson, M., Danielsson, E., Kaiser, C., Renstrom, I.M., Warolen, M. & James, S.R. Insulin receptor activation and down-regulation by cationic lipid transfection reagents. BMC. Cell Biol. 5, 7 (2004).
12. Rosser, M.P., Xia, W., Hartsell, S., McCaman, M., Zhu, Y., Wang, S., Harvey, S., Bringmann, P. & Cobb, R.R. Transient transfection of CHO-K1-S using serum-free medium in suspension: a rapid mammalian protein expression system. Protein Expr. Purif. 40, 237-243 (2005).
13. 2+-phosphate transfection efficiency in low-density neuronal cultures. Nat. Protoc. 1, 695-700 (2006).
14. Jiang, M., Deng, L. & Chen, G. High Ca(2+)-phosphate transfection efficiency enables single neuron gene analysis. Gene Ther. 11, 1303-1311 (2004).
15. Han, D.P., Kim, H.G., Kim, Y.B., Poon, L.L. & Cho, M.W. Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. Virology 326, 140-149 (2004).
16. Toledo, J.R., Prieto, Y., Oramas, N. & Sanchez, O. Polyethylenimine-based transfection method as a simple and effective way to produce recombinant lentiviral vectors. Appl. Biochem. Biotechnol. 157, 538-544 (2009).